ITGR

MKT CAP:$3B

Integer Holdings Corporation

Market Cap

$3B

Healthcare·Medical - Devices·🇺🇸 United States·NYSE

Healthcare·Medical - Devices·🇺🇸·NYSE

Stock Price

$85.16+$8.38 (+10.91%)

Apr 22, 2026

Company Details

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for inter...

CEO

Payman Khales

IPO Date

Sep 29, 2000

Website

www.integer.net

Key Metrics TTM

Revenue

$1.9B

+8.0% YoY

Net Income

$103M

EPS (Diluted)

$2.87

Free Cash Flow

$149M

Revenue / Share

$52.74

Gross Margin

27.1%

Operating Margin

12.1%

Net Margin

5.5%

FCF Margin

8.1%

P/S

1.6x

P/E

28.5x

Earnings Reports

Q1 2026

Apr 30, 2026

PENDING

FY 2025

Feb 23, 2026

$1.9B+8.0%EPS $2.89

Q4 2025

Feb 23, 2026

$472M+5.0%EPS $1.38

Q3 2025

Oct 23, 2025

$468M+8.4%EPS $1.11

Q2 2025

Jul 24, 2025

$476M+11.4%EPS $1.04

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$306M	$82M	$33M
Q1 22	$311M	$81M	$22M
Q2 22	$350M	$93M	$33M
Q3 22	$343M	$87M	$29M
Q1 23	$379M	$97M	$34M
Q2 23	$400M	$93M	$40M
Q3 23	$397M	$105M	$49M
Q4 23	$405M	$110M	$44M
Q1 24	$408M	$109M	$39M
Q2 24	$428M	$118M	$54M
Q3 24	$431M	$117M	$58M
Q4 24	$449M	$117M	$57M
Q1 25	$437M	$121M	$50M
Q2 25	$476M	$131M	$59M
Q3 25	$468M	$126M	$56M
Q4 25	$472M	$125M	$60M

Valuation

Quarter	P/S	P/E
Q3 21	2.5x	33.2x
Q1 22	2.4x	34.8x
Q2 22	2.3x	35.1x
Q3 22	2.2x	41.7x
Q1 23	2.1x	47.9x
Q2 23	2.0x	39.7x
Q3 23	1.9x	36.5x
Q4 23	1.9x	32.4x
Q1 24	1.8x	29.9x
Q2 24	1.8x	27.9x
Q3 24	1.8x	25.8x
Q4 24	1.7x	24.5x
Q1 25	1.7x	38.2x
Q2 25	1.6x	35.5x
Q3 25	1.6x	33.8x
Q4 25	1.6x	28.5x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	$49M	$37M
Q1 22	$18M	$7M
Q2 22	$19M	$7M
Q3 22	$28M	$7M
Q1 23	$6M	-$19M
Q2 23	$56M	$23M
Q3 23	$62M	$37M
Q4 23	$56M	$19M
Q1 24	$23M	-$6M
Q2 24	$47M	$16M
Q3 24	$72M	$45M
Q4 24	$63M	$44M
Q1 25	$31M	$6M
Q2 25	$44M	$69M
Q3 25	$66M	$46M
Q4 25	$55M	$28M

Capital Expenditures

Quarter	CapEx
Q3 21	$11M
Q1 22	$11M
Q2 22	$12M
Q3 22	$20M
Q1 23	$25M
Q2 23	$33M
Q3 23	$25M
Q4 23	$37M
Q1 24	$29M
Q2 24	$31M
Q3 24	$26M
Q4 24	$19M
Q1 25	$25M
Q2 25	$25M
Q3 25	$19M
Q4 25	$27M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	+29.5%	+38.9%
Q1 22	+15.6%	+19.5%
Q2 22	+20.5%	+24.0%
Q3 22	+9.8%	+14.9%
Q1 23	+24.0%	+26.5%
Q2 23	+28.6%	+24.9%
Q3 23	+13.3%	+9.7%
Q4 23	+18.0%	+15.2%
Q1 24	+7.7%	+7.1%
Q2 24	+7.0%	+3.7%
Q3 24	+8.7%	+7.3%
Q4 24	+11.1%	+8.7%
Q1 25	+7.3%	+5.1%
Q2 25	+11.4%	+11.7%
Q3 25	+8.4%	+10.1%
Q4 25	+5.0%	+5.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$3M	1.1%
Q1 22	$5M	1.6%
Q2 22	$6M	1.7%
Q3 22	$5M	1.5%
Q1 23	$6M	1.6%
Q2 23	$6M	1.4%
Q3 23	$5M	1.4%
Q4 23	$6M	1.5%
Q1 24	$7M	1.7%
Q2 24	$6M	1.3%
Q3 24	$6M	1.4%
Q4 24	$6M	1.3%
Q1 25	$7M	1.6%
Q2 25	$6M	1.2%
Q3 25	$5M	1.1%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q3 21	$12M	$34M
Q1 22	$16M	$40M
Q2 22	$15M	$41M
Q3 22	$16M	$38M
Q1 23	$19M	$42M
Q2 23	$17M	$37M
Q3 23	$14M	$41M
Q4 23	$13M	$45M
Q1 24	$15M	$46M
Q2 24	$16M	$46M
Q3 24	$12M	$44M
Q4 24	$11M	$47M
Q1 25	$14M	$51M
Q2 25	$14M	$52M
Q3 25	$11M	$50M
Q4 25	$10M	$53M

Revenue Segments

Quarter	Medical Segment	Non-Medical Segment	Cardiac Rhythm Management & Neuromodulation	Cardio And Vascular	Other Markets
Q3 21	$296M	$9M	—	—	—
Q1 22	$302M	$9M	—	—	—
Q2 22	$340M	$10M	—	—	—
Q3 22	$331M	$12M	—	—	—
Q1 23	$364M	$15M	—	—	—
Q2 23	$389M	$11M	—	—	—
Q3 23	$396M	$9M	—	—	—
Q4 23	$404M	$9M	—	—	—
Q1 24	$407M	$8M	—	—	—
Q2 24	$427M	$9M	—	—	—
Q3 24	—	—	$165M	$241M	$25M
Q1 25	—	—	$160M	$259M	$18M
Q2 25	—	—	$172M	$287M	$18M
Q3 25	—	—	$169M	$277M	$21M
Q4 25	—	—	$167M	$284M	$21M

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$26M	$0	$26M
Q2 22	$16M	$0	$16M
Q3 22	$20M	$0	$20M
Q4 22	$24M	$0	$24M
Q1 23	$41M	$0	$41M
Q2 23	$39M	$0	$39M
Q3 23	$32M	$0	$32M
Q4 23	$24M	$0	$24M
Q1 24	$42M	$0	$42M
Q2 24	$34M	$0	$34M
Q3 24	$36M	$0	$36M
Q4 24	$47M	$0	$47M
Q1 25	$32M	$0	$32M
Q2 25	$23M	$0	$23M
Q3 25	$59M	$0	$59M
Q4 25	$17M	$0	$17M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	33M	+0.2%	+0.7%
Q1 22	33M	-0.0%	+0.5%
Q2 22	33M	+0.1%	+0.5%
Q3 22	33M	-0.0%	+0.2%
Q1 23	34M	+0.7%	+0.8%
Q2 23	34M	+0.3%	+1.2%
Q3 23	34M	+0.3%	+1.3%
Q4 23	34M	+0.6%	+2.0%
Q1 24	35M	+3.0%	+4.2%
Q2 24	36M	+1.5%	+5.5%
Q3 24	36M	+0.7%	+6.0%
Q4 24	36M	+1.3%	+6.6%
Q1 25	34M	-6.4%	-3.1%
Q2 25	36M	+5.3%	+0.5%
Q3 25	36M	-0.3%	-0.5%
Q4 25	35M	-1.3%	-3.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	$40.7K	8K
Q1 22	$34.5K	9K
Q2 22	$38.9K	9K
Q3 22	$38.1K	9K
Q1 23	$37.9K	10K
Q2 23	$40.0K	10K
Q3 23	$39.7K	10K
Q4 23	$38.5K	11K
Q1 24	$38.8K	11K
Q2 24	$40.8K	11K
Q3 24	$41.1K	11K
Q4 24	$40.9K	11K
Q1 25	$39.8K	11K
Q2 25	$43.3K	11K
Q3 25	$42.5K	11K
Q4 25	$42.9K	11K

Revenue / Employee